Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase NA 1

Status

Recruiting 3Completed 1

Sponsor Class

OTHER 95INDUSTRY 72NIH 25OTHER_GOV 5NETWORK 4

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Gynecologic 4

Conditions

Breast Neoplasms 49Prostatic Neoplasms 38Carcinoma, Non-Small-Cell Lung 28Neoplasms 24Precursor Cell Lymphoblastic Leukemia-Lymphoma 23Multiple Myeloma 23Lymphoma 20Leukemia, Myeloid, Acute 17Colorectal Neoplasms 17Melanoma 14Lung Neoplasms 13Hodgkin Disease 11Brain Neoplasms 11Medulloblastoma 10Lymphoma, Non-Hodgkin 10HIV Infections 10Glioblastoma 10Squamous Cell Carcinoma of Head and Neck 9Pancreatic Neoplasms 9Neoplasm Metastasis 9Leukemia, Biphenotypic, Acute 9Leukemia 9Head and Neck Neoplasms 9Neuroblastoma 8Hematologic Neoplasms 8Ependymoma 8Glioma 7Carcinoma, Renal Cell 7Astrocytoma 7Sarcoma, Kaposi 6

Interventions

Letrozole 1Diploidy 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × Fallopian Tube Neoplasms × 1 year × Clear all
NCT06466382 2026-05-05

OVPrecision

Swiss GO Trial Group

Phase NA Recruiting
60 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT05659381 2026-04-16

HOTT

GOG Foundation

Phase 3 Recruiting
220 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06274541 2026-04-13

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

Cancer Trials Ireland

Completed
200 enrolled
Gynecologic

Fallopian Tube Neoplasms

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting
540 enrolled
Gynecologic

Fallopian Tube Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡